Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

127 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product.
Rubin JS, Bottaro DP, Aaronson SA. Rubin JS, et al. Among authors: bottaro dp. Biochim Biophys Acta. 1993 Dec 23;1155(3):357-71. doi: 10.1016/0304-419x(93)90015-5. Biochim Biophys Acta. 1993. PMID: 8268192 Review. No abstract available.
Isoforms of human HGF and their biological activities.
Chan A, Rubin J, Bottaro D, Hirschfield D, Chedid M, Aaronson SA. Chan A, et al. EXS. 1993;65:67-79. EXS. 1993. PMID: 8380745 Review.
Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
Alimandi M, Wang LM, Bottaro D, Lee CC, Kuo A, Frankel M, Fedi P, Tang C, Lippman M, Pierce JH. Alimandi M, et al. EMBO J. 1997 Sep 15;16(18):5608-17. doi: 10.1093/emboj/16.18.5608. EMBO J. 1997. PMID: 9312020 Free PMC article.
Molecular targeting of growth factor receptor-bound 2 (Grb2) as an anti-cancer strategy.
Dharmawardana PG, Peruzzi B, Giubellino A, Burke TR Jr, Bottaro DP. Dharmawardana PG, et al. Among authors: bottaro dp. Anticancer Drugs. 2006 Jan;17(1):13-20. doi: 10.1097/01.cad.0000185180.72604.ac. Anticancer Drugs. 2006. PMID: 16317285 Review.
Inhibition of angiogenesis by growth factor receptor bound protein 2-Src homology 2 domain bound antagonists.
Soriano JV, Liu N, Gao Y, Yao ZJ, Ishibashi T, Underhill C, Burke TR Jr, Bottaro DP. Soriano JV, et al. Among authors: bottaro dp. Mol Cancer Ther. 2004 Oct;3(10):1289-99. Mol Cancer Ther. 2004. PMID: 15486196
Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways.
Day RM, Soon L, Breckenridge D, Bridges B, Patel BK, Wang LM, Corey SJ, Bottaro DP. Day RM, et al. Among authors: bottaro dp. Oncogene. 2002 Mar 28;21(14):2201-11. doi: 10.1038/sj.onc.1205289. Oncogene. 2002. PMID: 11948403
The hepatocyte growth factor isoform NK2 activates motogenesis and survival but not proliferation due to lack of Akt activation.
Mungunsukh O, Lee YH, Bottaro DP, Day RM. Mungunsukh O, et al. Among authors: bottaro dp. Cell Signal. 2016 Aug;28(8):1114-23. doi: 10.1016/j.cellsig.2016.05.012. Epub 2016 May 17. Cell Signal. 2016. PMID: 27224506
Targeting the hepatocyte growth factor/Met pathway in cancer.
De Silva DM, Roy A, Kato T, Cecchi F, Lee YH, Matsumoto K, Bottaro DP. De Silva DM, et al. Among authors: bottaro dp. Biochem Soc Trans. 2017 Aug 15;45(4):855-870. doi: 10.1042/BST20160132. Epub 2017 Jul 3. Biochem Soc Trans. 2017. PMID: 28673936 Review.
Preliminary evaluation of urinary soluble Met as a biomarker for urothelial carcinoma of the bladder.
McNeil BK, Sorbellini M, Grubb RL 3rd, Apolo A, Cecchi F, Athauda G, Cohen B, Giubellino A, Simpson H, Agarwal PK, Coleman J, Getzenberg RH, Netto GJ, Shih J, Linehan WM, Pinto PA, Bottaro DP. McNeil BK, et al. Among authors: bottaro dp. J Transl Med. 2014 Oct 21;12:199. doi: 10.1186/1479-5876-12-199. J Transl Med. 2014. PMID: 25335552 Free PMC article.
Heparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1.
Ozen E, Gozukizil A, Erdal E, Uren A, Bottaro DP, Atabey N. Ozen E, et al. Among authors: bottaro dp. PLoS One. 2012;7(8):e42717. doi: 10.1371/journal.pone.0042717. Epub 2012 Aug 13. PLoS One. 2012. PMID: 22912725 Free PMC article.
127 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback